Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

De La Rue's £300m authentication unit sale expected to close in May

(Sharecast News) - Banknote printing business De La Rue said on Monday that the £300.0m sale of its authentication business was now expected to close at the beginning of May. De La Rue, which agreed to the sale of the unit back in October, stated that all conditions to the exercise of options granted under the put and call agreement for the sale of the division have now been either satisfied or waived.

As a result, De La Rue and Crane NXT entered into a share purchase agreement. On completion of the share purchase agreement, the full sale amount will become payable in cash, with £15.0m being held in escrow for up to 18 months post-completion and £30.0m being paid to the trustee of the group's defined benefit pension scheme by way of an accelerated deficit repair contribution.

De La Rue added that a portion of the proceeds will also be applied to repay its revolving credit facility in full.

As of 0835 BST, De La Rue shares were up 2.46% at 110.66p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.